<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="236">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04590378</url>
  </required_header>
  <id_info>
    <org_study_id>UU-PE001</org_study_id>
    <nct_id>NCT04590378</nct_id>
  </id_info>
  <brief_title>Pulmonary Embolism and COVID-19</brief_title>
  <acronym>COVID-19-PE</acronym>
  <official_title>Evaluation of the Patients With COVID-19 in Terms of Pulmonary Embolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uşak University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uşak University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The charts of patients who developed pulmonary embolism in the course of COVID-19 will be&#xD;
      evaluated, retrospectively. Clinical features and laboratory data will be analyzed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with COVID-19 infection will be evaluated retrospectively. Demographic data,&#xD;
      clinical and laboratory findings will be recorded. Findings of patients with pulmonary&#xD;
      embolism and withour pulmonary embolism will be compared.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>pulmonary embolism</measure>
    <time_frame>1 year</time_frame>
    <description>development of pulmonary embolism</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intensive care unit</measure>
    <time_frame>1 year</time_frame>
    <description>need for admission to intensive care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>1 year</time_frame>
    <description>mortality rate due to pulmonary embolism</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Covid-19</condition>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>Covid-19 Patients with Pulmonary embolism</arm_group_label>
    <description>Clinically demonstared cases infected with COVID-19 who developed pulmonary embolism.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Covid-19 Patients without Pulmonary embolism</arm_group_label>
    <description>Clinically demonstared cases infected with COVID-19 who did not develop pulmonary embolism.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>intensive care unit admission ratio</intervention_name>
    <description>intensive care unit admission ratio</description>
    <arm_group_label>Covid-19 Patients with Pulmonary embolism</arm_group_label>
    <arm_group_label>Covid-19 Patients without Pulmonary embolism</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All COVID-19 patients with positive RT-PCR tests will be analyzed retrospectively. Patients&#xD;
        with and without pulmonary embolism will be compared in terms of age, gender, side disease,&#xD;
        hospitalization in intensive care, mortality rates etc.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - All patients with positive RT-PCR for COVID-19&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - All patients with negative RT-PCR for COVID-19&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Cevdet Duran, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uşak University Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cevdet Duran, M.D.</last_name>
    <phone>+905334298585</phone>
    <email>drcduran@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Uşak University</name>
      <address>
        <city>Usak</city>
        <zip>64200</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cevdet Duran, Prof.</last_name>
      <phone>02762212121</phone>
      <email>drcduran@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Canan Akkus, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hakan Yilmaz, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Barış Sevinç, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 14, 2020</study_first_submitted>
  <study_first_submitted_qc>October 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>October 15, 2020</last_update_submitted>
  <last_update_submitted_qc>October 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

